Answering Your Frequently Asked Questions
The Cell & Gene Therapies Pricing & Reimbursement Summit is a focused, senior‑level forum addressing the most complex market access challenges facing advanced therapies today. As cell and gene therapy programs mature, pricing strategy, reimbursement pathways, and payer alignment have become decisive factors in determining sustainable patient access and long‑term commercial success.
This meeting brings together biopharma and biotech leaders, payers, HTAs, policy experts, and market access specialists to examine real‑world evidence requirements, value frameworks, innovative reimbursement models, and global launch strategy across cell and gene therapies. The FAQs below provide practical information on the Summit’s focus, audience, agenda structure, and opportunities for engagement, supporting informed decisions across registration, partnership, and participation.
Explore the Agenda
Dive into the only agenda that unpacks real world cell and gene therapy pricing, reimbursement, evidence generation, payer strategy, and policy shifts shaping market viability today.
Partner With Us
Position your solutions at the center of cell and gene therapy market access, payer engagement, and commercialization strategy conversations attended by the field’s leading decisionmakers.
Join Biopharma Experts
Network with the manufacturers, payers, policy leaders, and access strategists defining the future of cell and gene therapy coverage, affordability, and sustainable patient access.